A judge on Friday extended a temporary block of the Trump Administration’s drastic cuts in medical research funding.
A new parking ramp near Carver Hawkeye arena and a child care center among UI projects that seek approval at the Board of ...
The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.
Andrew Stanton is a Newsweek weekend reporter based in Maine. His role is reporting on U.S. politics and social issues. Andrew joined Newsweek in 2021 from The Boston Globe. He is a graduate of ...
Overall, the research community is justifiably concerned that the proposed NIH funding cuts could have far-reaching effects on medical innovation, public health, and patient outcomes. While ...
Clinical research conducted at the National Institutes of Health campus in Bethesda ... new research projects on NIH’s campus, and a pause on recruiting new patients for any clinical studies ...
Indirect cost funding from the NIH is now capped at 15%, dramatically lower than UGA’s standard 51% rate for federally-funded on-campus research. “Indirect costs, also known as facilities and ...
UW contributed information to this legal challenge, describing the potential impacts this directive could have on campus, according to the statement. UW added to the importance of receiving NIH funds.
Nurses at Ludeman Developmental Center in Park Forest say a new parking ... safety of the patient,” she said of Ludeman administration. Because of the size of Ludeman’s campus, walking ...
the lawmakers asked for “an end to this administrative chaos” while describing Trump’s actions as “sharply disrupting” work at the agency in Bethesda. “NIH attracts our nation’s ...
The proposed cuts have since been temporarily blocked by a judge. As the largest funder of UC research, the NIH contributed $2.6 billion in research funding to the university in 2024.Currently ...
along with a prohibition on starting any new research projects on NIH’s campus and a pause on recruiting new patients for any clinical studies at the agency. “It’s incredibly frustrating,” says ...